Currents Plus is a review of recent literature pertaining to pharmacotherapy in psychiatry, by Jack E. Rosenblatt, M.D.
Our entries consist of summaries of published studies, observational reports, meta-analyses, and “data-mining” analyses of medical registries and insurance claims databases. Summaries of content are accompanied by commentary about experimental or cognitive bias that may affect interpretation of observations or conclusions from findings.
Jack E. Rosenblatt, M.D., is a Board-certified adult, adolescent, and child psychiatrist who began his formal education at a young age after admission to Vanderbilt University’s Admission Without Diploma Program; graduated college on an accelerated schedule and entered Vanderbilt Medical School’s M.D.-Ph.D. Program during adolescence.
After combined training in Medicine and Pharmacology, he entered a specialized psychiatric residency at Johns Hopkins in Baltimore and the National Institutes of Health in Bethesda, Maryland, where he received clinical training in psychiatry and clinical research intended to provide the knowledge-base upon which practice can be based to achieve optima of efficacy, safety, tolerability, and new questions to drive heuristic perpetuity; he additionally was afforded laboratory space and assistance to carry out basic research on how psychiatric drugs exert their therapeutic and adverse effects.
Dr. Rosenblatt has published his research in credible, peer-reviewed journals such as Science, the Archives of General Psychiatry, American Journal of Psychiatry, and the Journal of Clinical Psychopharmacology, and has consulted on the design, methodology, and analysis of findings of studies submitted to major journals for publication. Since leaving NIH, he has turned his attention to teaching and training a new generation of psychiatrists to vet the credibility and quality of studies whose authors aspire to convey a new generation of evidence. He is the Founding Editor of the critically acclaimed international literature review Currents in Affective Illness (1982-2013, Bethesda, Maryland) that is in process of adaptation to a not-for-profit website intended for English-speaking clinicians seeking generalizable evidence with discussion of artifacts and potential cognitive and commercial biases.